Roger S. Newton, Director at Esperion Therapeutics, Inc. (ESPR), sold 34,846 shares at $50.01 ($1.7M) on 2018-10-16, disclosed to the SEC on 2018-10-18.
Open-market sale of $1.7M ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 9,400 | $470K | 27.0% |
| 2 | $50.02 | 12,673 | $634K | 36.4% |
| 3 | $50.02 | 12,673 | $634K | 36.4% |
| 4 | $50.00 | 100 | $5K | 0.3% |
| Total | $50.02 avg | 34,846 | $1.7M | 100% |
| Filing → |
| ESPR | SELL | 2018-08-29 | $904K | — | Filing → |
| ESPR | SELL | 2018-08-22 | $365K | — | Filing → |
| ESPR | SELL | 2018-03-29 | $1.8M | — | Filing → |